ONE-TWENTY TWO: Trading Financial Markets
Exploring the poetry in financial markets for students of money and economy since the year 2000.
AT40 = 69.9% of stocks are trading above their respective 40-day moving averages (DMAs) – ended 12 straight days overbought AT200 = 59.7% of stocks are trading above their respective 200DMAs VIX = 9.9 Short-term Trading Call: bullish (see caveats below) Commentary AT40 (T2108), the percentage of stocks trading above their respective 40-day moving averages … Read more
I first wrote about Ulta Beauty (ULTA) in early September, 2016 after it confirmed a bearish breakdown from support at its 50-day moving average (DMA). I never traded the stock and missed the entire recovery and 31% gain to the last peak and all-time high in early June, 2017. It took another bearish breakdown for … Read more
AT40 = 73.8% of stocks are trading above their respective 40-day moving averages (DMAs) – overbought day #7 AT200 = 59.7% of stocks are trading above their respective 200DMAs VIX = 9.7 Short-term Trading Call: bullish Commentary This is what a lift-off for an extended overbought rally looks like. The S&P 500 (SPY) followed its … Read more
A month ago, I wrote about the near seasonal pattern of speculators accumulating net long contracts in gold and silver from July troughs to October peaks. THIS year, the speculators started up on schedule but aborted the mission as net longs peaked well ahead of October. Source: Oanda’s CFTC’s Commitments of Traders So seasonal patterns … Read more
DexCom (DXCM) is a maker of continuous glucose monitoring (CGM) systems. Last week, the stock of the company cratered after Abbott Laboratories (ABT) received FDA approval of its competing FreeStyle Libre flash CGM. It is the first system that allows diabetics to check and monitor glucose levels without sticking themselves. In response to the news, … Read more